ELV Stock Analysis: Buy, Sell, or Hold?
ELV - Elevance Health, Inc.
$393.89
-0.94 (-0.24%)
▼
5d:
-1.99%
30d:
+1.04%
90d:
+36.18%
BUY
HIGH Confidence
Analysis Updated: Jun 22, 2026 12:00 AM ET
Earnings: Jul 16, 2026
22d
Smart Money Accumulation
None View Scanner →
Strength: 3.6/10
Get Alerted When ELV Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
✅ BUY SIGNAL: ELV shows strong fundamentals and good volume confirmation. Solid entry point despite slightly low pricing.
✅ BUY SIGNAL: ELV shows strong fundamentals and good volume confirmation. Solid entry point despite slightly low pricing.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$481.17
Based on 6.4% avg growth
INTRINSIC VALUE TODAY
$298.77
Trading above historical range
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 12.1x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: ELV is currently trading at $393.88, which is considered slightly low relative to its 30-day fair value range of $388.46 to $407.55. From a valuation perspective, the stock is trading at a premium (Forward PE: 13.5) compared to its historical average (12.1). At these levels, the market is pricing in 3.6% annual earnings growth.
Technical Outlook: Technically, ELV is in a uptrend. The price is currently testing key support at $386.76. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, ELV is in a uptrend. The price is currently testing key support at $386.76. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
SLIGHTLY LOW
Historical Trading Range
$388.46 -
$407.55
Company Quality Score
58/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
78.1%
All Signals
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Mixed technical signals (40/100)
- BULLISH: High volume confirmation
- NEUTRAL: Near Wall St target ($415.81)
- BULLISH: Expecting earnings turnaround to 3.6% growth with 2.6% revenue growth
Trading Range Analysis
30-Day Trading Range
$388.46 -
$407.55
Current vs Trading Range
SLIGHTLY LOW
Support & Resistance Levels
Support Level
$386.76
Resistance Level
$426.66
Current Trend
Uptrend
Technical data as of
Jun 9, 2026
Fundamental Context
Forward P/E (Next Year Est.)
13.50
Wall Street Target
$415.81
(+5.3%)
Revenue Growth (YoY)
2.6%
Earnings Growth (YoY)
-16.8%
Profit Margin
2.6%
Valuation Premium vs History
+3.6% premium
PE vs Historical
13.5 vs 12.1
FAIR
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
+3.6%
(market-implied from PE analysis)
1-Year Target
$409.03
(+4%)
2-Year Target
$423.76
(+7%)
3-Year Target
$439.01
(+11%)
3-Yr Target (if PE normalizes)
(PE: 14→12)
PE COMPRESSION
$393.51
(0%)
Earnings growth offset by PE compression
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 21.8, Growth: 8.7%)
$818.26
(+107%)
Base:
(SPY PE: 13.5, Growth: 8.7%)
$507.16
(+29%)
Bear:
(PE: 11.5, Growth: 8.7%)
$431.08
(+9%)
📈
Valuation based on Current Earnings
RECOVERY PLAY: Stock looks expensive now (16x PE), but valuation improves significantly next year (14x PE) as earnings recover.
Trailing PE: 16.48 | Current EPS (TTM): $23.58
Bull Case
$530.06
(+34%)
Analyst growth 24.0%, PE expands to 18.1
Base Case
$481.88
(+22%)
Market implied 24.0%, PE stable at 16.5
Bear Case
$264.18
(-33%)
Severe decline -20.0%, PE contracts to 14.0
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
Share & Embed Analysis
Last updated: June 23, 2026 11:34 AM ET
Data refreshes hourly during market hours. Next update: 12:34 PM
Data refreshes hourly during market hours. Next update: 12:34 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is ELV showing a specific setup today?
Insider Activity (6 Months)
3
Buys
3
Sells
0
Net
INSIDERS SELLING
Recent Transactions
Ro Khanna
SELL
2026-03-30
Amy W Schulman
SELL
26 shares
2026-03-12
Ro Khanna
BUY
2026-02-24
Top Rated Healthcare Plans Stocks
Top-rated stocks in Healthcare Plans by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
CVS
CVS Health Corp |
STRONG BUY
28 analysts |
$105 | 66 BUY |
|
UNH
UnitedHealth Group Incor… |
STRONG BUY
27 analysts |
$410 | 54 HOLD |
|
CI
Cigna Corp |
STRONG BUY
25 analysts |
$341 | 58 HOLD |
|
HUM
Humana Inc |
HOLD
26 analysts |
$302 | 60 HOLD |
|
CNC
Centene Corp |
BUY
19 analysts |
$61 | 60 HOLD |
Advanced ELV Option Strategies
Professional options setups generated by AI based on today's ELV price and gamma walls.
